Study of the Application of Magnetic Fields for the Treatment of Parkinson's Disease

Inclusion Criteria: * Idiopathic Parkinson's Disease * Stable optimized anti-PD drugs for at least 4 weeks * PDQ-39 Summary Index between 15 and 45 * Ambulatory * Willing to maintain regular medication regime throughout study * Able to abstain from starting in new treatments to improve PD symptoms during course of study. * No prior surgical interventions for Parkinson's Disease * Non-demented * Minimum of 30 years of age, but not older than 85 * Capable of giving full written consent Exclusion Criteria: * Atypical Parkinsonism such as progressive supranuclear palsy, multiple system atrophy, CBDG etc. * Subjects may not have any of the following: active brain tumor, strokes, hydrocephalus, any other neurologic or non-neuro problem which may affect symptomatic expression of patients parkinsonism. * Consumption of medications that can produce drug induced parkinsonism * Chronic pain not associated with PD * Current or past history of major psychiatric disturbance * No typical or non-typical anti-psychotics for treatment of drug induced psychosis. * Chronic fatigue * Epilepsy or history of epilepsy * Seizures or taking medication for epilepsy * HIV or other autoimmune disorders * History of ECT * Uncontrolled hypertension * Advanced pulmonary disease * Unstable cardiac disease * Prior surgical interventions for Parkinson's disease * Prosthetics or implants comprised of ferrous metals * Pacemaker, vagus nerve stimulators, or other functional electrical stimulators such as those commonly used for pain * Pregnant, breast feeding or planning pregnancy prior to study end * Dementia, developmental disability, psychiatric disorder or other cognitive impairment * Any significant medical condition that may require alteration of medical therapy during the study, or major medical condition which may interfere with the study activity.